Paclitaxel protein-bound Pregnancy and Breastfeeding Warnings
Paclitaxel protein-bound is also known as: Abraxane
Paclitaxel protein-bound Pregnancy Warnings
Animal studies have revealed evidence of embryotoxicity and fetotoxicity, as indicated by intrauterine mortality, increased resorptions, reduced numbers of litters and live fetuses, reduction in fetal body weight and increase in fetal anomalies. (Fetal anomalies included soft tissue and skeletal malformations such as eye bulge, folded retina, microphthalmia, and dilation of brain ventricles.) There are no controlled data in human pregnancy. Men should be advised not to father a child while receiving treatment with paclitaxel protein-bound particles. Animal studies of the effects of paclitaxel protein-bound particles on males mating with untreated females were reported to have resulted in significantly reduced fertility accompanied by decreased pregnancy rates and increased loss of embryos in mated females. Testicular atrophy/degeneration and a low incidence of skeletal and soft tissue anomalies were also reported. FDA pregnancy category D: There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
FDA pregnancy category: D Paclitaxel protein-bound particles should only be given during pregnancy when there are no alternatives and benefit outweighs risk.
Paclitaxel protein-bound Breastfeeding Warnings
A decision should be made to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother. Excreted into human milk: Unknown Excreted into animal milk: Yes
Animal studies have revealed that intravenous administration of carbon-14 labeled paclitaxel on days 9 to 10 postpartum, concentrations of radioactivity in milk were higher than in plasma and declined in parallel with the plasma concentrations.
- paclitaxel protein-bound Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.